Global Trends in Stem Cell Therapy Clinical Trials: A 10-Year Retrospective, 2007–2016

Global Trends in Stem Cell Therapy Clinical Trials: A 10-Year Retrospective, 2007–2016

12:27, June 19 2017

By GlobalData

Patrick Alyes, MEng, and Revati Tatake, PhD, GlobalData, examine trends in stem cell clinical research

This whitepaper provides a review of global clinical trials for stem cell therapy initiated between 2007 and 2016. The data for this review were derived from the Clinical Trials Database of GlobalData's Pharma Intelligence Center. The aim of this paper is to provide analyses of the main features of these trials according to 10-year trends, where relevant.

Summary of Contents

4 - Introduction
4 - Report Scope
4 - Methodology
4 - Organizations Mentioned
5 - Stem Cell Therapy Trial Landscape
5 - Introduction
5 - Stem Cell Therapy Clinical Trials by Phase and Sponsor Type, 2007-2016
8 - Single-Country and Multinational Stem Cell Therapy Trials, 2007-2016
9 - Average Size of Stem Cell Therapy Clinical Trials, 2007-2016
11 - Stem Cell Therapy Clinical Trials by Therapy Area, 2007-2016
12 - Top Indications for Stem Cell Therapy Clinical Trials, 2007-2016
14 - Stem Cell Therapy Clinical Trials by Status, 2007-2016
15 - Top Sponsors for Stem Cell Therapy Clinical Trials, 2007-2016
17 - Top Interventions Investigated in Stem Cell Therapy Clinical Trials, 2007-2016
18 - Stem Cell Therapy Clinical Trials by Country, 2007-2016
19 - Summary
20 - About the Authors
20 - Associate Analyst, Clinical Trials Database
20 - Global Director of Databases and Analytics
21 - About the Pharmaceutical Clinical Trials Team
22 - About GlobalData
22 - Contact Us
23 - Disclaimer

Download Whitepaper

Global Trends in Stem Cell Therapy Clinical Trials: A 10-Year Retrospective, 2007–2016
More Whitepapers